This is not the most recent version of the article. View current version (20 OCT 2015)

Intervention Protocol

You have free access to this content

Additional plerixafor to granulocyte colony-stimulating factors for haematopoietic stem cell mobilisation for autologous transplantation in malignant lymphoma or multiple myeloma patients

  1. Tim Hartmann1,
  2. Kai Hübel2,
  3. Ina Monsef3,
  4. Andreas Engert3,
  5. Nicole Skoetz3,*

Editorial Group: Cochrane Haematological Malignancies Group

Published Online: 25 JUN 2013

DOI: 10.1002/14651858.CD010615


How to Cite

Hartmann T, Hübel K, Monsef I, Engert A, Skoetz N. Additional plerixafor to granulocyte colony-stimulating factors for haematopoietic stem cell mobilisation for autologous transplantation in malignant lymphoma or multiple myeloma patients (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 6. Art. No.: CD010615. DOI: 10.1002/14651858.CD010615.

Author Information

  1. 1

    University of Cologne, Cochrane Haematological Malignancies Group, Department I of Internal Medicine, Cologne, Germany

  2. 2

    University Hospital of Cologne, Department I of Internal Medicine, Center of Integrated Oncology Köln Bonn, Cologne, Germany

  3. 3

    University Hospital of Cologne, Cochrane Haematological Malignancies Group, Department I of Internal Medicine, Cologne, Germany

*Nicole Skoetz, Cochrane Haematological Malignancies Group, Department I of Internal Medicine, University Hospital of Cologne, Kerpener Str. 62, Cologne, 50924, Germany. nicole.skoetz@uk-koeln.de.

Publication History

  1. Publication Status: New
  2. Published Online: 25 JUN 2013

SEARCH

This is not the most recent version of the article. View current version (20 OCT 2015)

References

Additional references

Basak 2011
Bensinger 2009
Broxmeyer 2005
  • Broxmeyer HE, Orschell CM, Clapp DW, Hangoc G, Cooper S, Plett PA, et al. Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist. The Journal of Experimental Medicine 2005;201(8):1307-18. [PUBMED: 15837815]
Deeks 2011
  • Deeks JJ, Higgins JPT, Altman DG. Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011.
DiPersio 2009a
  • DiPersio JF, Micallef IN, Stiff PJ, Bolwell BJ, Maziarz RT, Jacobsen E, et al. Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma. Journal of Clinical Oncology 2009;27:4767-73.
DiPersio 2009b
  • DiPersio JF, Stadtmauer EA, Nademanee A, Micallef IN, Stiff PJ, Kaufman JL, et al. Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma. Blood 2009;113:5720-6.
Gertz 2010
GLOBOCAN 2008
  • International Agency for Research on Cancer. Globocan 2008. http://globocan.iarc.fr.
Gobbi 2013
  • Gobbi PG, Ferreri AJ, Ponzoni M, Levis A. Hodgkin lymphoma. Critical reviews in oncology/hematology 2013;85(2):216-37. [PUBMED: 22867814]
Greb 2008
Hatse 2003
  • Hatse S, Princen K, Vermeire K, Gerlach LO, Rosenkilde MM, Schwartz TW, et al. Mutations at the CXCR4 interaction sites for AMD3100 influence anti-CXCR4 antibody binding and HIV-1 entry. FEBS Letters 2003;546(2-3):300-6. [PUBMED: 12832058]
Herold 2013
  • Herold G. Innere Medizin. Herold G, 2013.
Higgins 2011
  • Higgins JPT, Deeks JJ (editors). Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011.
Higgins 2011a
  • Higgins JPT, Deeks JJ, Altman DG (editors). Chapter 16: Special topics in statistics. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011.
Higgins 2011b
  • Higgins JPT, Altman DG. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011.
Hintringer 2010
  • Hintringer K. Plerixafor (Mozobil ®) for autologous stem cell transplantation in patients with lymphoma and multiple myeloma. Horizon Scanning in Oncology 2010; Vol. 8.
Hubel 2011
  • Hubel K, Fresen MM, Salwender H, Basara N, Beier R, Theurich S, et al. Plerixafor with and without chemotherapy in poor mobilizers: results from the German compassionate use program. Bone Marrow Transplantation 2011;46:1045-52.
Jaffe 2009
  • Jaffe ES. The 2008 WHO classification of lymphomas: Implications for clinical practice and translational research. Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. 2009:523-31. [PUBMED: 20008237]
Jantunen 2010
Jantunen 2012
  • Jantunen E, Sureda A. The evolving role of stem cell transplants in lymphomas. Biology of Blood and Marrow Transplantation 2012;18(5):660-73. [PUBMED: 21963876]
Jemal 2009
Kyle 2003
Lefebvre 2011
  • Lefebvre C, Manheimer E, Glanville J. Chapter 6: Searching for studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011.
Malard 2011
  • Malard F, Kroger N, Gabriel IH, Hubel K, Apperley JF, Basak GW, et al. Plerixafor for autologous peripheral blood stem cell mobilization in patients previously treated with fludarabine or lenalidomide. Biology of Blood and Marrow Transplantation 2012;18(2):314-7.
Maziarz 2013
  • Maziarz RT, Nademanee AP, Micallef IN, Stiff PJ, Calandra G, Angell J, et al. Plerixafor plus granulocyte colony-stimulating factor improves the mobilization of hematopoietic stem cells in patients with non-Hodgkin lymphoma and low circulating peripheral blood CD34(+) cells. Biology of Blood and Marrow Transplantation 2013;19(4):670-5. [PUBMED: 23333777]
Moher 2009
  • Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-Analyses: the PRISMA statement. Journal of Clinical Epidemiology 2009;62(10):1006-12. [PUBMED: 19631508]
Naumann-Winter 2012
  • Naumann-Winter F, Greb A, Borchmann P, Bohlius J, Engert A, Schnell R. First-line tandem high-dose chemotherapy and autologous stem cell transplantation versus single high-dose chemotherapy and autologous stem cell transplantation in multiple myeloma, a systematic review of controlled studies. Cochrane Database of Systematic Reviews 2012, Issue 10. [DOI: 10.1002/14651858.CD004626.pub3]
Parmar 1998
Phekoo 2004
Rancea 2011
  • Rancea M, Monsef I, von Tresckow B, Engert A, Skoetz N. High-dose chemotherapy followed by autologous stem cell transplantation for refractory/relapsed Hodgkin lymphoma patients. Cochrane Database of Systematic Reviews 2011, Issue 11. [DOI: 10.1002/14651858.CD009411]
Review Manager (RevMan)
  • The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
Sant 2010
  • Sant M, Allemani C, Tereanu C, De Angelis R, Capocaccia R, Visser O, et al. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood 2010;116(19):3724-34.
Schaaf 2012
  • Schaaf M, Reiser M, Borchmann P, Engert A, Skoetz N. High-dose therapy with autologous stem cell transplantation versus chemotherapy or immuno-chemotherapy for follicular lymphoma in adults. Cochrane Database of Systematic Reviews 2012, Issue 1. [DOI: 10.1002/14651858.CD007678.pub2]
Siegel 2012
Smith 2011
  • Smith A, Howell D, Patmore R, Jack A, Roman E. Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network. British Journal of Cancer 2011;105(11):1684-92.
Sterne 2011
  • Sterne JAC, Egger M, Moher D. Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011.
Tierney 2007